Trials / Completed
CompletedNCT03308643
Effect of Oxytocin Infusion on Blood Loss During Abdominal Myomectomy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effects of oxytocin infusion during abdominal myomectomy.
Detailed description
Myomectomy is indicated for symptomatic uterine fibroids. Fibroids have blood supply and 20% of the abdominal myomectomy cases might require blood transfusion because of the nature of the surgery. Oxytocin infusion is one of the intervention to decrease blood loss during myomectomy. To evaluate the effects and benefits of oxytocin infusion during abdominal myomectomy we decide to conduct this randomized study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxytocin | Patients will receive intravenous oxytocin infusion just before the surgery after the induction of general anesthesia. |
| OTHER | saline | Patients will receive intravenous normal saline infusion just before the surgery after the induction of general anesthesia. |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2018-05-10
- Completion
- 2018-05-10
- First posted
- 2017-10-12
- Last updated
- 2018-05-21
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03308643. Inclusion in this directory is not an endorsement.